Bioforce Nanosciences Holdings annual gross profit
2017
2018
2019
2022
2023
2024
2025
Bioforce Nanosciences Holdings Gross Profit Growth & History (BFNH)
Bioforce Nanosciences Holdings's gross profit was $0 for fiscal 2025.
View full Bioforce Nanosciences Holdings company overviewBioforce Nanosciences Holdings annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2019 | 2019-12-31 | $4,360 | −$305 | −6.54% |
| 2018 | 2018-12-31 | $4,665 | $3,410 | +271.71% |
| 2017 | 2017-12-31 | $1,255 | — | — |
Bioforce Nanosciences Holdings quarterly gross profit
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2019 | 2019-12-31 | $1 | — | — |
| Q3 2019 | 2019-09-30 | $1,722 | $130 | +8.17% |
| Q2 2019 | 2019-06-30 | $947 | −$470 | −33.17% |
| Q1 2019 | 2019-03-31 | $1,690 | — | — |
| Q3 2018 | 2018-09-30 | $1,592 | — | — |
| Q2 2018 | 2018-06-30 | $1,417 | — | — |
Bioforce Nanosciences Holdings gross profit trends
Between the periods ended 2017-12-31 and 2025-12-31, Bioforce Nanosciences Holdings's gross profit decreased from $1,255 to $0, a change of −$1,255. The latest reported quarter, Q2 2026, shows $0.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioforce Nanosciences Holdings source filings ↗